Correlation Analysis Between Multi-Drug Resistance Phenotype and Virulence Factor Expression of Clinical Pseudomonas
Wenli Xu1, Runcheng Zhou1, Jingwei Pan1
1School of Medicine, Foshan University, Foshan 528225, China.
Abstract:
Pseudomonas aeruginosa (PA), as a common pathogen of nosocomial infections, has been experiencing an increasing rate of drug resistance with the widespread use and abuse of antimicrobial drugs. High-drug-resistance and high-virulence phenotypes are two distinctive features of the strong pathogenicity of multi-drug-resistant PA. Exploring the characterization of virulence factor expression and its relationship with the multi-drug resistance phenotype is essential to reduce the further development of resistance as well as a high standard of infection prevention and control. A total of 50 PA isolated from clinical practice were collected. The Kirby-Bauer test was used for drug-sensitive screening, and the results showed that 16 strains were resistant and 16 strains were sensitive. The drug resistance rate of multi-drug-resistant PA against cefepime, cefazolin, ampicillin, and imipenem was up to 100%. The multi-drug-resistant groups were superior in producing pyocyanin and forming biofilm to the sensitive groups. The distribution of isolates with different swarming motility capacities and elastase levels did not show pronounced differences among the multi-drug-resistant and sensitive groups. In addition, biofilm formation was moderately associated with imipenem resistance. Among the strains with strong virulence factor expression, the gene bands showed little difference, suggesting that the gene is highly homologous. The virulence factor matrix analysis showed that there were different degrees of correlation among the 4 virulence factors. The correlation between multidrug-resistant PA and virulence factor expression is complex. PA, which were good at producing pyocyain and forming biofilm, were highly resistant to cephalosporins, beta-lactams and carbepenems; hence, such drugs are not proper for anti-infective treatment in clinics.
Insights
Multi-drug-resistant Pseudomonas aeruginosa strains exhibit enhanced pyocyanin production and biofilm formation, correlating with resistance to cephalosporins, beta-lactams, and carbapenems. This highlights complex interactions between resistance and virulence factors in this pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Pseudomonas aeruginosa (PA) is a frequent cause of hospital-acquired infections.
- Increasing antimicrobial drug resistance and high-virulence phenotypes characterize multi-drug-resistant PA.
- Understanding virulence factor expression in relation to drug resistance is crucial for infection control.
Purpose of the Study:
- To investigate the relationship between multi-drug resistance and virulence factor expression in clinical isolates of Pseudomonas aeruginosa.
- To identify potential therapeutic targets by characterizing the pathogenicity of resistant PA strains.
Main Methods:
- Collected 50 clinical isolates of Pseudomonas aeruginosa.
- Performed Kirby-Bauer testing for drug sensitivity screening.
- Assessed pyocyanin production, biofilm formation, swarming motility, and elastase levels.
Main Results:
- 100% resistance to cefepime, cefazolin, ampicillin, and imipenem observed in multi-drug-resistant PA.
- Multi-drug-resistant strains showed superior pyocyanin production and biofilm formation compared to sensitive strains.
- Biofilm formation was moderately associated with imipenem resistance; swarming motility and elastase levels showed no significant differences.
Conclusions:
- Multi-drug-resistant Pseudomonas aeruginosa strains with high pyocyanin production and biofilm formation are resistant to cephalosporins, beta-lactams, and carbapenems.
- The correlation between multi-drug resistance and virulence factor expression in PA is complex.
- Certain antibiotics are not suitable for treating infections caused by these highly resistant and virulent PA strains.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Regulation of Bacterial Virulence
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance


